GC said 2-4 yrs for commercialization of ESS-W. If the 10 patient study hits a grand slam, with wound experts pushing for approval, does it have the potential of approval in less than 2?

He said that one thought leaders stated that ESS not getting approved was the biggest disappointment of his career as it is so unique and very much needed.

With 60 burn centers across the US, uptake could be concentrated and quick with limited resources needed to get it out there as compared to other products.